P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN

• Karthik Ramasamy,
• K Martin Kortum,
• Evi Zhuleku,
• Elena Zamagni,
• Tim D’estrube,
• Soham Shukla,
• Moritz Lehne,
• Marco Ghiani,
• Maya Hanna,
• Ulf Maywald,
• Thomas Wilke,
• Lenka Kellermann,
• Sue Perera

Affiliations

Karthik Ramasamy

1 Oxford University Hospitals, NHS Foundation Trust, Department of Haematology, Freiburg, Germany

K Martin Kortum

2 University Hospital Würzburg, Würzburg, Germany

Evi Zhuleku

3 Cytel Inc, Berlin, Germany

Elena Zamagni

4 Alma Mater Studiorum - Università di Bologna, Bologna, Italy

Tim D’estrube

5 GSK, London, United Kingdom

Soham Shukla

6 GSK, Upper Providence, United States

Moritz Lehne

7 Cytel Inc, Berlin, Germany

Marco Ghiani

8 Institut für Pharmakoökonomie und Arzneimittellogistik, Wismar, Germany

Maya Hanna

9 GSK, Upper Providence, United States

Ulf Maywald

10 AOK PLUS – Projektwerkstatt Dresden, Dresden, Germany

Thomas Wilke

8 Institut für Pharmakoökonomie und Arzneimittellogistik, Wismar, Germany

Lenka Kellermann

11 OncologyInformationService, Freiburg im Breisgau, Germany

Sue Perera

5 GSK, London, United Kingdom